Vimarsana
Biggest News Aggregation in the World

Page 21 - Aadi Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aadi Bioscience Today - Breaking & Trending Today

Aadi Bioscience Announces Planned Leadership Transition - Vimarsana News

Aadi Bioscience Announces Planned Leadership Transition

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined...

Mirati Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Updates - Vimarsana News

Mirati Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Updates

/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter of...

Aadi Bioscience Announces Planned Leadership Transition - Vimarsana News

Aadi Bioscience Announces Planned Leadership Transition

LOS ANGELES, Nov. 8, 2022 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision ...

Aadi Bioscience to Present at Upcoming Investor Conferences - Vimarsana News

Aadi Bioscience to Present at Upcoming Investor Conferences

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...

Mirati, Aadi To Evaluate Adagrasib, Nab-sirolimus Combination To Treat NSCLC, Other Solid Tumors - Vimarsana News

Mirati, Aadi To Evaluate Adagrasib, Nab-sirolimus Combination To Treat NSCLC, Other Solid Tumors

(RTTNews) - Oncology company Mirati Therapeutics, Inc. (MRTX) and biopharmaceutical company Aadi Bioscience, Inc. (AADI) announced Wednesday a cli...